Printer Friendly Version

Send to a Friend

Amgen Inc. has completed construction of a 29,000-sf process-development laboratory at its manufacturing site in West Greenwich, Rhode Island.  The $26-million facility will house nearly 80 researchers engaged in discovering more efficient processes of manufacturing Embrel, a rheumatoid arthritis drug. Amgen is also constructing an eight-story, 362,000-sf lab and office building in Cambridge's Kendall Square in Massachusetts to house R&D operations. Completion of the Cambridge facility is expected in the first quarter of 2007.